# SV Life Sciences Fund IV CF, L.P. — Form D

SV Life Sciences Fund IV CF, L.P. of BOSTON, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2022-03-25. The offering totals $421.4M, of which $421.4M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2022-03-25
- Form: D
- Accession: 0001917895-22-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $421.4M
- Amount sold: $421.4M
- Investors: 44
- Date of first sale: 2021-08-13
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-438954

## Issuer

- Name: SV Life Sciences Fund IV CF, L.P.
- CIK: 0001877185
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: ONE BOSTON PLACE, SUITE 3900, BOSTON, MA, 02108
- Phone: 617-367-8100

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Houman Ashrafian | Executive Officer | London, X0 |
| Michael Balmuth | Executive Officer | San Francisco, CA |
| Kate Bingham | Executive Officer | London, X0 |
| THOMAS FLYNN | Executive Officer | DENVER, CO |
| Eugene Hill | Executive Officer | Boston, MA |
| Paul LaViolette | Executive Officer | Seattle, WA |
| GREG MADDEN | Executive Officer | St. Paul, MN |
| Michael Ross | Executive Officer | South San Francisco, CA |
| N/A SV Life Sciences Fund IV CF (GP), LLC | Executive Officer | Boston, MA |

## More

- [CIK 1877185 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1877185&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001917895-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.